|Bid||56.93 x 800|
|Ask||62.51 x 1100|
|Day's Range||57.60 - 60.28|
|52 Week Range||28.50 - 86.42|
|Beta (5Y Monthly)||1.70|
|PE Ratio (TTM)||N/A|
|Earnings Date||Jul 27, 2021 - Aug 02, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||75.40|
SEATTLE & SAN FRANCISCO, Jun 15, 2021--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, and the Parker Institute for Cancer Immunotherapy (PICI) announced today that they are collaborating on an expansive molecular characterization project for cellular therapies. The collaboration will define the characteristics that make a cell therapy effective, providing a standardized approach to developing CAR-T regimens that ma
NanoString Technologies, Inc. ( NASDAQ:NSTG ) shareholders might be concerned after seeing the share price drop 29% in...
NanoString to webcast presentation from the Jefferies Virtual Healthcare conference.